{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:58:18Z","timestamp":1791428298496,"version":"4.3.3"},"reference-count":56,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Surg"],"published-print":{"date-parts":[[2026,10,1]]},"abstract":"<jats:sec id=\"ab-ssc260002-1\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Many patients are diagnosed with atypical lesions or lobular carcinoma in situ (LCIS); however, evidence- and consensus-based guidelines for the management of many of these lesions are limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ssc260002-2\">\n                    <jats:title>Observations<\/jats:title>\n                    <jats:p>The American Society of Breast Surgeons, in collaboration with the Society of Breast Imaging and College of American Pathology, assembled a steering group to create guidelines for the management of atypical lesions and LCIS, inclusive of flat epithelial atypia (FEA), atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), classic LCIS (C-LCIS), and the variant LCIS forms pleomorphic LCIS (P-LCIS) and florid LCIS (F-LCIS). The natural history of ADH, ALH, and C-LCIS suggests that these lesions are associated with an elevated future breast cancer risk; therefore, patients diagnosed with these lesions should be recommended to undergo comprehensive risk assessment and counseling about breast cancer risk-reducing strategies. The magnitude of future breast cancer risk associated with P-LCIS and F-LCIS remains uncertain, yet if these lesions are determined to be hormone receptor positive, risk-reducing medications should be considered. There is no evidence that FEA is associated with an elevated future breast cancer risk. A second pathology review confirmation is recommended for ADH, should be considered for FEA, and is not necessary for ALH or LCIS. Currently available evidence supports the need to diagnostically excise most ADH, P-LCIS, and F-LCIS cases identified on core biopsy, although some ADH cases fulfilling strict criteria and multidisciplinary consensus can be observed. P-LCIS and F-LCIS require a negative margin, but ADH does not. ALH and C-LCIS can be safely observed if the core biopsy diagnosis is concordant with imaging features (ie, radiographic-pathologic concordance is established). Provided radiologic-pathologic concordance is confirmed, diagnostic excision is generally not indicated after a diagnosis of FEA alone.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-ssc260002-3\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>These guidelines provide evidence-informed, consensus-based recommendations for the management of atypical lesions of the breast, including ADH, ALH, FEA, C-LCIS, P-LCIS, and F-LCIS. Practicing clinicians who treat patients with atypical breast lesions or LCIS should consider integrating these guidelines into clinical management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamasurg.2026.3552","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T15:30:26Z","timestamp":1787153426000},"page":"1076","source":"Crossref","is-referenced-by-count":1,"title":["American Society of Breast Surgeons, Society of Breast Imaging, and College of American Pathology 2026 Guidelines for the Management of Proliferative Lesions With Atypia and Lobular Carcinoma In Situ"],"prefix":"10.1001","volume":"161","author":[{"given":"Faina","family":"Nakhlis","sequence":"first","affiliation":[{"name":"Department of Surgery, Beth Israel Deaconess Medical Center, Dana-Farber Cancer Institute, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bedrosian","sequence":"additional","affiliation":[{"name":"Department of Breast Surgical Oncology, University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tari A.","family":"King","sequence":"additional","affiliation":[{"name":"Department of Surgery, Emory University School of Medicine, Atlanta, Georgia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha L.","family":"Heller","sequence":"additional","affiliation":[{"name":"Department of Radiology, New York University Grossman School of Medicine, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly H.","family":"Allison","sequence":"additional","affiliation":[{"name":"Department of Pathology, Stanford Medicine, Stanford, California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Boolbol","sequence":"additional","affiliation":[{"name":"Department of Surgery, Nuvance Health, Poughkeepsie, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen A.","family":"Pass","sequence":"additional","affiliation":[{"name":"Department of Surgery, NYU Langone Health, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie M.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Surgery, Legacy Health, Portland, Oregon"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy C.","family":"Boughey","sequence":"additional","affiliation":[{"name":"Department of Surgery, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Surgery, NorthShore Endeavor Health, Evanston, Illinois"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"12","key":"ssc260002r1","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.1001\/jamasurg.2025.4392","article-title":"American Society of Breast Surgeons and Society of Breast Imaging 2025 guidelines for the management of benign breast fibroepithelial lesions.","volume":"160","author":"Rosenberger","year":"2025","journal-title":"JAMA Surg"},{"issue":"3","key":"ssc260002r2","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1245\/s10434-019-07814-w","article-title":"The Tyrer-Cuzick model inaccurately predicts invasive breast cancer risk in women with LCIS.","volume":"27","author":"Valero","year":"2020","journal-title":"Ann Surg Oncol"},{"issue":"33","key":"ssc260002r3","doi-asserted-by":"publisher","first-page":"3945","DOI":"10.1200\/JCO.2015.61.4743","article-title":"Lobular carcinoma in situ: a 29-year longitudinal experience evaluating clinicopathologic features and breast cancer risk.","volume":"33","author":"King","year":"2015","journal-title":"J Clin Oncol"},{"issue":"2","key":"ssc260002r4","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1007\/s10549-021-06499-8","article-title":"Accuracy of the breast cancer surveillance consortium model among women with LCIS.","volume":"194","author":"Eroglu","year":"2022","journal-title":"Breast Cancer Res Treat"},{"issue":"22","key":"ssc260002r5","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1093\/jnci\/dji372","article-title":"Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study.","volume":"97","author":"Fisher","year":"2005","journal-title":"J Natl Cancer Inst"},{"issue":"9","key":"ssc260002r6","doi-asserted-by":"publisher","first-page":"2509","DOI":"10.1245\/s10434-017-5867-6","article-title":"Population-based analysis of breast cancer incidence and survival outcomes in women diagnosed with lobular carcinoma in situ.","volume":"24","author":"Wong","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"ssc260002r7","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1056\/NEJMsr1407164","article-title":"Atypical hyperplasia of the breast\u2013risk assessment and management options.","volume":"372","author":"Hartmann","year":"2015","journal-title":"N Engl J Med"},{"issue":"19","key":"ssc260002r8","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1200\/JCO.2006.09.0217","article-title":"Stratification of breast cancer risk in women with atypia: a Mayo cohort study.","volume":"25","author":"Degnim","year":"2007","journal-title":"J Clin Oncol"},{"issue":"6","key":"ssc260002r9","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1111\/his.13035","article-title":"Histological features associated with diagnostic agreement in atypical ductal hyperplasia of the breast: illustrative cases from the B-Path study.","volume":"69","author":"Allison","year":"2016","journal-title":"Histopathology"},{"issue":"4","key":"ssc260002r10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1002\/path.982","article-title":"Ductal epithelial proliferations of the breast: a biological continuum? comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.","volume":"195","author":"Boecker","year":"2001","journal-title":"J Pathol"},{"issue":"3","key":"ssc260002r11","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/path.1973","article-title":"Quantitative analysis of allele imbalance supports atypical ductal hyperplasia lesions as direct breast cancer precursors.","volume":"209","author":"Larson","year":"2006","journal-title":"J Pathol"},{"issue":"4","key":"ssc260002r12","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/PAS.0b013e318161d1a5","article-title":"Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family.","volume":"32","author":"Abdel-Fatah","year":"2008","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"ssc260002r13","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1111\/j.1365-2559.2010.03568.x","article-title":"Breast cancer precursors revisited: molecular features and progression pathways.","volume":"57","author":"Lopez-Garcia","year":"2010","journal-title":"Histopathology"},{"issue":"2","key":"ssc260002r14","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1038\/modpathol.3800514","article-title":"Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast.","volume":"19","author":"O\u2019Malley","year":"2006","journal-title":"Mod Pathol"},{"issue":"7","key":"ssc260002r15","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1136\/jcp.2004.025239","article-title":"Pathological diagnosis of columnar cell lesions of the breast: are there issues of reproducibility?","volume":"58","author":"Tan","year":"2005","journal-title":"J Clin Pathol"},{"issue":"4","key":"ssc260002r16","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1245\/s10434-024-16762-z","article-title":"Incidence of adjacent synchronous ipsilateral infiltrating carcinoma and\/or ductal carcinoma in situ in patients diagnosed with flat epithelial atypia by core needle biopsy (TBCRC 034).","volume":"32","author":"Nakhlis","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"ssc260002r17","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1111\/his.14091","article-title":"The 2019 World Health Organization classification of tumours of the breast.","volume":"77","author":"Tan","year":"2020","journal-title":"Histopathology"},{"issue":"3","key":"ssc260002r19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1186\/bcr788","article-title":"Tavassoli FA, Devilee P: Pathology and genetics: tumours of the breast and female genital organs. WHO Classification of Tumours series - volume IV. Lyon, France: IARC Press.","volume":"6","author":"Hanby","year":"2004","journal-title":"Breast Cancer Res"},{"issue":"10","key":"ssc260002r21","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1002\/cncr.29243","article-title":"Flat epithelial atypia and risk of breast cancer: a Mayo cohort study.","volume":"121","author":"Said","year":"2015","journal-title":"Cancer"},{"issue":"2","key":"ssc260002r22","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.ejso.2019.10.029","article-title":"Pure flat epithelial atypia identified on core needle biopsy does not require excision.","volume":"46","author":"Liu","year":"2020","journal-title":"Eur J Surg Oncol"},{"issue":"12","key":"ssc260002r23","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1245\/s10434-017-6059-0","article-title":"Flat epithelial atypia on core biopsy and upgrade to cancer: a systematic review and meta-analysis.","volume":"24","author":"Rudin","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"ssc260002r24","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1245\/s10434-021-10827-z","article-title":"Atypical lobular hyperplasia and classic lobular carcinoma in situ can be safely managed without surgical excision.","volume":"29","author":"Laws","year":"2022","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"ssc260002r25","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1158\/1055-9965.EPI-09-0745","article-title":"Rates of atypical ductal hyperplasia have declined with less use of postmenopausal hormone treatment: findings from the Breast Cancer Surveillance Consortium.","volume":"18","author":"Menes","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"11","key":"ssc260002r27","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1002\/1097-0142(19850601)55:11<2698::AID-CNCR2820551127>3.0.CO;2-A","article-title":"Atypical hyperplastic lesions of the female breast: a long-term follow-up study.","volume":"55","author":"Page","year":"1985","journal-title":"Cancer"},{"issue":"2","key":"ssc260002r28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/cncr.22408","article-title":"Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses\u2019 Health Study.","volume":"109","author":"Collins","year":"2007","journal-title":"Cancer"},{"issue":"2","key":"ssc260002r29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1158\/1940-6207.CAPR-13-0222","article-title":"Understanding the premalignant potential of atypical hyperplasia through its natural history: a longitudinal cohort study.","volume":"7","author":"Hartmann","year":"2014","journal-title":"Cancer Prev Res (Phila)"},{"issue":"1","key":"ssc260002r30","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jamaoncol.2016.3022","article-title":"Subsequent breast cancer risk following diagnosis of atypical ductal hyperplasia on needle biopsy.","volume":"3","author":"Menes","year":"2017","journal-title":"JAMA Oncol"},{"key":"ssc260002r31","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjsurg.2025.116598","article-title":"Risk assessment tools for women with breast atypia: a systematic review.","volume":"250","author":"Nierenberg","year":"2025","journal-title":"Am J Surg"},{"issue":"18","key":"ssc260002r32","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1200\/JCO.2017.75.9480","article-title":"Model for predicting breast cancer risk in women with atypical hyperplasia.","volume":"36","author":"Degnim","year":"2018","journal-title":"J Clin Oncol"},{"issue":"1","key":"ssc260002r33","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1148\/radiol.2019190748","article-title":"Upgrade rate of percutaneously diagnosed pure atypical ductal hyperplasia: systematic review and meta-analysis of 6458 lesions.","volume":"294","author":"Schiaffino","year":"2020","journal-title":"Radiology"},{"issue":"5","key":"ssc260002r34","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1245\/s10434-025-16933-6","article-title":"Trends in atypical ductal hyperplasia diagnosis and upgrade: a 20-year experience and impact of MRI use on upgrade rates.","volume":"32","author":"Zaveri","year":"2025","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"ssc260002r35","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1245\/s10434-010-1127-8","article-title":"Atypical ductal hyperplasia in directional vacuum-assisted biopsy of breast microcalcifications: considerations for surgical excision.","volume":"18","author":"Nguyen","year":"2011","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"ssc260002r36","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s10549-017-4253-1","article-title":"Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia.","volume":"164","author":"Pe\u00f1a","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"ssc260002r37","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1245\/s10434-016-5512-9","article-title":"Long-term safety of observation in selected women following core biopsy diagnosis of atypical ductal hyperplasia.","volume":"24","author":"Menen","year":"2017","journal-title":"Ann Surg Oncol"},{"issue":"12","key":"ssc260002r38","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1097\/00000478-199212000-00001","article-title":"Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria.","volume":"16","author":"Schnitt","year":"1992","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"ssc260002r39","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/M15-0964","article-title":"Variability in pathologists\u2019 interpretations of individual breast biopsy slides: a population perspective.","volume":"164","author":"Elmore","year":"2016","journal-title":"Ann Intern Med"},{"issue":"1","key":"ssc260002r40","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1177\/33.1.2578144","article-title":"An improved method of preparing nuclei for absorption cytophotometry.","volume":"33","author":"Bose","year":"1985","journal-title":"J Histochem Cytochem"},{"key":"ssc260002r41","doi-asserted-by":"crossref","first-page":"i3069","DOI":"10.1136\/bmj.i3069","article-title":"Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study.","volume":"353","author":"Elmore","year":"2016","journal-title":"BMJ"},{"issue":"2","key":"ssc260002r42","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/his.12387","article-title":"Understanding diagnostic variability in breast pathology: lessons learned from an expert consensus review panel.","volume":"65","author":"Allison","year":"2014","journal-title":"Histopathology"},{"issue":"2","key":"ssc260002r43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/1066896916662154","article-title":"Atypical ductal hyperplasia bordering on ductal carcinoma in situ.","volume":"25","author":"Tozbikian","year":"2017","journal-title":"Int J Surg Pathol"},{"key":"ssc260002r44","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/1746-1596-9-121","article-title":"Inter-observer variability between general pathologists and a specialist in breast pathology in the diagnosis of lobular neoplasia, columnar cell lesions, atypical ductal hyperplasia and ductal carcinoma in situ of the breast.","volume":"9","author":"Gomes","year":"2014","journal-title":"Diagn Pathol"},{"issue":"7","key":"ssc260002r45","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/modpathol.2011.66","article-title":"Atypical ductal hyperplasia: interobserver and intraobserver variability.","volume":"24","author":"Jain","year":"2011","journal-title":"Mod Pathol"},{"issue":"6","key":"ssc260002r46","doi-asserted-by":"crossref","first-page":"e932","DOI":"10.1097\/SLA.0000000000004849","article-title":"Risk of breast cancer in selected women with atypical ductal hyperplasia who do not undergo surgical excision.","volume":"276","author":"Kilgore","year":"2022","journal-title":"Ann Surg"},{"issue":"1","key":"ssc260002r47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2023.107292","article-title":"European guidelines for the diagnosis, treatment and follow-up of breast lesions with uncertain malignant potential (B3 lesions) developed jointly by EUSOMA, EUSOBI, ESP (BWG) and ESSO.","volume":"50","author":"Rubio","year":"2024","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"ssc260002r48","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1245\/s10434-022-12568-z","article-title":"Screening MRI does not increase cancer detection or result in an earlier stage at diagnosis for patients with high-risk breast lesions: a propensity score analysis.","volume":"30","author":"Laws","year":"2023","journal-title":"Ann Surg Oncol"},{"key":"ssc260002r50","doi-asserted-by":"crossref","DOI":"10.1016\/j.anndiagpath.2020.151481","article-title":"American Registry of Pathology Expert Opinions: the spectrum of lobular carcinoma in situ: diagnostic features and clinical implications.","volume":"45","author":"Schnitt","year":"2020","journal-title":"Ann Diagn Pathol"},{"issue":"2","key":"ssc260002r51","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10549-025-07771-x","article-title":"Immediate and ipsilateral recurrence rates and treatment recommendations for patients with pleomorphic and florid lobular carcinoma in situ.","volume":"213","author":"Middleton","year":"2025","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"ssc260002r52","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1245\/s10434-011-2034-3","article-title":"Lobular in-situ neoplasia on breast core needle biopsy: imaging indication and pathologic extent can identify which patients require excisional biopsy.","volume":"19","author":"Rendi","year":"2012","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"ssc260002r53","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/cncr.27841","article-title":"Classic lobular carcinoma in situ and atypical lobular hyperplasia at percutaneous breast core biopsy: outcomes of prospective excision.","volume":"119","author":"Murray","year":"2013","journal-title":"Cancer"},{"issue":"2","key":"ssc260002r54","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1148\/radiol.13121730","article-title":"Atypical lobular hyperplasia and lobular carcinoma in situ at core breast biopsy: use of careful radiologic-pathologic correlation to recommend excision or observation.","volume":"269","author":"Atkins","year":"2013","journal-title":"Radiology"},{"issue":"1","key":"ssc260002r55","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1245\/s10434-018-6937-0","article-title":"Evaluating the rate of upgrade to invasive breast cancer and\/or ductal carcinoma in situ following a core biopsy diagnosis of non-classic lobular carcinoma in situ.","volume":"26","author":"Nakhlis","year":"2019","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"ssc260002r56","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1245\/s10434-015-4922-4","article-title":"Incidence of adjacent synchronous invasive carcinoma and\/or ductal carcinoma in-situ in patients with lobular neoplasia on core biopsy: results from a prospective multi-institutional registry (TBCRC 020).","volume":"23","author":"Nakhlis","year":"2016","journal-title":"Ann Surg Oncol"},{"key":"ssc260002r18","author":"Eby","year":"2025"},{"key":"ssc260002r20","volume-title":"Breast Tumours: WHO Classification of Tumours Series","author":"Schnitt","year":"2019"},{"key":"ssc260002r26","volume-title":"Breast Tumours: WHO Classification of Tumours Series","author":"Allison","year":"2019"},{"key":"ssc260002r49","volume-title":"Breast Tumours: WHO Classification of Tumours Series","author":"Chen","year":"2019"}],"container-title":["JAMA Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/articlepdf\/2853197\/jamasurgery_nakhlis_2026_sc_260002_1791304706.38415.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T15:00:57Z","timestamp":1791385257000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamasurgery\/fullarticle\/2853197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":56,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamasurg.2026.3552","relation":{},"ISSN":["2168-6254"],"issn-type":[{"value":"2168-6254","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10,1]]}}}